Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

$26.98 +5.37%
EARNINGS ANALYTICS
search

Hemab Therapeutics Holdings, Inc. Common Stock (COAG) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was +2.58% (May 21, 2026) and its biggest decline was +2.58% (May 21, 2026).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±2.58%

Positive %

100.0%

Negative %

0.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
May 21, 2026 ☀ PRE $26.98 $27.02 $26.62 9,052 +2.58% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±2.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

5 most recent
Form Date Filed View on EDGAR
10-Q 20260521 open_in_new SEC.gov
4 20260521 open_in_new SEC.gov
8-K 20260521 open_in_new SEC.gov
3 20260514 open_in_new SEC.gov
4 20260514 open_in_new SEC.gov

Frequently asked about COAG earnings

How much does COAG stock move after earnings? expand_more

Over 1 reports, COAG has moved an average of ±2.58% the session after earnings, closing higher 100.0% of the time.

What was COAG's biggest post-earnings move? expand_more

COAG's largest post-earnings gain on record was +2.58% on May 21, 2026, and its largest decline was +2.58% on May 21, 2026.

Where can I find Hemab Therapeutics Holdings, Inc. Common Stock's SEC filings? expand_more

All of Hemab Therapeutics Holdings, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers